antifungal drugs

Related to antifungal drugs: fluconazole

antifungal drugs

Used to prevent or treat fungal infections, locally (on the skin) or systemically.
Mentioned in ?
References in periodicals archive ?
Resistance to echinocandin-class antifungal drugs. Drug Resist Updat.
Determination of minimum inhibitory concentrations of various antifungal agents in clinical isolates of Candida species
This approval also marks the second time a drug is being approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, a pathway, advanced by Congress, to spur development of drugs targeting infections that lack effective therapies.
United States : FDA approves new drug for treatment-resistant forms of tuberculosis that affects the lungs
Food & Drug Administration (FDA) for treating some of the most drug-resistant forms of tuberculosis (TB).A The new drug was approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway) as part of a three-drug, six-month, all-oral regimen for the treatment of people with extensively drug-resistant TB (XDR-TB) or multidrug-resistant TB (MDR-TB) who are treatment-intolerant or non-responsive (collectively "highly drug-resistant TB").
FDA Approves New Treatment For Tuberculosis
CorMedix announced that Phoebe Mounts, EVP and general counsel, presented at a public meeting on July 12, 2019 hosted by FDA discussing the Limited Population Pathway for Antibacterial and Antifungal Drugs. In her presentation, Dr.
CorMedix presents on LPAD at FDA public meeting
Currently, only three major classes of clinical antifungal drugs exist.
Starving fungus can help beat drug-resistant fungal infection
Following the passage of the limited population pathway for antibacterial and antifungal drugs established by the 21st Century Cures Act the FDA can now grant approval for some anti-infective products on the basis of limited clinical data.
Hope on the Hudson
auris is often resistant to major antifungal drugs that are typically used to treat such infections.
What you need to know about superbug C.auris
In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species.
In vitro antifungal susceptibility of Malassezia spp. to azole drugs
Arikayce (amikacin liposome inhalation suspension) is the first drug to be approved under the Limited Population Pathway for Antibacterial and Antifungal Drugs, or LPAD pathway, established by Congress under the 21st Century Cures Act.
The US FDA approves the new antibacterial Arikayce drug to treat serious lung disease caused by MAC using a novel pathway
Arikayce is the first medication approved under the FDA's Limited Population Pathway for Antibacterial and Antifungal Drugs, or LPAD pathway, which encourages development and approval of antibacterial and antifungal drugs to treat certain serious or life-threatening infections.
FDA Approves New Drug for Antibiotic-Resistant Lung Disease; Arikayce approved to treat lung disease caused by Mycobacterium avium complex bacteria
Data regarding costs of antifungal drugs, hospital, and ICU stay were provided by each participant hospital for each patient.
Monetary costs and hospital burden associated with the management of invasive fungal infections in Mexico: a multicenter study
Meanwhile an increase in the emergence of new pathogenic species difficult to diagnose and treat has been observed (Coleman et al., 2008); this increase is not only due to the frequent use of antifungal drugs to treat these kinds of infections but also due to therapeutic drug overdose.
Antifungal susceptibility profile of diferent yeasts isolates from wild animals, cow's milk with subclinical mastitis and hospital environment/Perfil de suscetibilidade antifungica de diferentes leveduras isoladas da microbiota de animais silvestres, leite com mastite subclinica e ambiente hospitalar

Dictionary browser ?
Full browser ?